| Literature DB >> 18288320 |
Edward F Fitzgerald1, Erin E Belanger, Marta I Gomez, Michael Cayo, Robert J McCaffrey, Richard F Seegal, Robert L Jansing, Syni-an Hwang, Heraline E Hicks.
Abstract
BACKGROUND: Polychlorinated biphenyls (PCBs) may accelerate the cognitive and motor dysfunction found in normal aging, but few studies have examined these outcomes and PCB exposure among older adults.Entities:
Keywords: adult; affective symptoms; hazardous waste; neurobehavioral manifestations; neuropsychological tests; polychlorinated biphenyls
Mesh:
Substances:
Year: 2008 PMID: 18288320 PMCID: PMC2235204 DOI: 10.1289/ehp.10432
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Map of the area of study: Hudson Falls, Fort Edward, and Glens Falls, New York.
Background characteristics of study participants.
| Characteristic | Mean ± SD (range) |
|---|---|
| Age (years) | 63.9 ± 6.0 (55–74) |
| BMI | 28.8 ± 6.3 (16.7–71.3) |
| Cigarette smoking (packs in last year) | 54.0 ± 138.9 (0–730) |
| Alcohol consumption (drinks per week) | 4.4 ± 6.6 (0–42) |
| Intellectual function (IQ) | 107.6 ± 8.8 (88.0–123.1) |
| Environmental contaminant concentrations | |
| Serum PCB (ppb) | |
| Wet weight | 3.6 ± 2.0 (1.0–19.3) |
| Lipid basis | 536.8 ± 287.4 (139.3–2116.6) |
| Serum DDE + DDT (ppb) | |
| Wet weight | 4.0 ± 3.6 (0–22.3) |
| Lipid basis | 738.4 ± 698.3 (3.0–4,082.2) |
| Serum PCB–TEQ (ppt–lipid basis) | 34.2 ± 128.8 (0.0–483) |
| Blood lead (μg/dL) | 3.1 ± 2.0 (0.5–17.7) |
| Blood mercury (μg/dL) | 0.3 ± 0.3 (0.1–2.1) |
| No. (%) | |
| Sex (male) | 127 (50) |
| Education | |
| Less than high school diploma | 20 (7.9) |
| High school diploma | 88 (34.8) |
| Some college | 65 (25.7) |
| 4-year college or more | 80 (31.6) |
| Occupational exposures (lifetime) | |
| Solvents | 90 (35.6) |
| Lead | 26 (10.3) |
The total number of responses varies because of missing data.
Probably exposed, as determined by industrial hygenist.
List of covariates included in final multivariate models by domain and neuropsychological test.
| Domain and test | Covariates (high-risk group) |
|---|---|
| Memory and learning | |
| CVLT, t-score | Sex (male), education (−), IQ (−), occupational solvent exposure (yes) |
| CVLT, trial 1 score | Sex (male), age (+), education (−), IQ (−), smoking (+),activity (−) |
| CVLT, short-delay free recall | Sex (male), IQ (−), employed (no), blood mercury (+) |
| CVLT, long-delay free recall | Sex (male), income (< $45,000), IQ (−) |
| CVLT, semantic cluster ratio | Sex (male), IQ (−), ACE inhibitors (yes), occupational solvent exposure (yes) |
| CVLT, learning slope | IQ (−), smoking (+), hobby personal solvent exposure |
| CVLT, perseverations | Hobby household pesticide exposure |
| CVLT, discriminability | Sex (male), IQ (−), diuretics (yes), thyroid hormones (yes) |
| CVLT, proactive interference | No covariates |
| CVLT, recognition hits vs long-delay free recall | Sex (male), income (< $45,000), IQ (−) |
| WMS, logical immediate recall | Income (< $45,000), IQ (−), hours of sleep (+) |
| WMS, logical delayed recall | Income (< $45,000), IQ (−), hours of sleep (+) |
| WMS, visual immediate recall | Age (+), IQ (−), acetaminophen (yes) |
| WMS, visual delayed recall | Age (+), IQ (−), trait anxiety (+), acetaminophen (yes) |
| Executive function | |
| Trail Making Test-Part A, time to complete | Age (+), education (−), IQ (−), hobby household pesticide exposure |
| Trail Making Test-Part B, time to complete | Age (+), income (< $45,000), IQ (−) |
| Stroop Color – Word Test, t-score | Sex (female), education (−), IQ (−), high blood pressure (yes) |
| WCST, categories completed | Age (+), IQ (−), beta blockers (yes), potassium supplements (no) |
| WCST, perseverative responses | Age (+), IQ (−) |
| WCST, perseverative errors | Age (+), IQ (−) |
| WCST, failures to maintain set | IQ (−), hours of sleep (+), employed (no) |
| Visual and spatial recognition | |
| Digit symbol coding | Sex (male), age (+), education (−), IQ (−), smoking (+) |
| Block design | IQ (−), state anxiety (+) |
| Reaction time | |
| Reaction time | Age (+), smoking (+), hours of sleep (−), arthritis (yes), NSAIDs (no) |
| Motor function | |
| Static motor steadiness, total time (dominant hand) | Sex (male) |
| Static motor steadiness, total time (nondominant hand) | No covariates |
| Pegboard completion time (dominant hand) | Age (+), IQ (−), diabetes (yes), arthritis (yes), anti-depressants (yes) |
| Pegboard completion time (nondominant hand) | Age (+), IQ (−), smoking (+), arthritis (yes), NSAIDS (no) |
| Finger tapping (dominant hand) | Sex (female), age (+) |
| Finger tapping (nondominant hand) | Sex (female) |
| Affective state | |
| BDI, total score | BMI (+), trait anxiety (+), employed (yes), gout medications (yes), antidepressants (yes) |
| Anxiety inventory, state anxiety t-score | BMI (+), Income (< $45,000), trait anxiety (+), activity level (−),sex hormones (yes) |
| Anxiety Inventory, trait anxiety t-score | Depression (+), state anxiety (+), employed (yes), sex hormones (yes) |
| Olfactory function | |
| Smell identification test | Age (+), marital status (not married/no live-in partner), smoking (+) |
Abbreviations: −, low score at high risk; +, high score at high risk; ACE, angiotensin-converting enzyme.
Low score = impairment.
High score = impairment.
Hobby personal exposures refers to nonoccupational exposure while personally using the substance.
Hobby household exposure refers to nonoccupational exposure while someone else in the house is using the substance.
Final multivariate modelsa for neuropsychological tests with serum total PCB concentration (lipid basis and log transformed).
| Domain and test | β | SE | ||
|---|---|---|---|---|
| Memory and learning | ||||
| CVLT, t-score | 240 | 0.706 | 1.601 | 0.660 |
| CVLT, trial 1 score | 238 | −0.576 | 0.271 | 0.035 |
| CVLT, short-delay free recall | 235 | 0.048 | 0.390 | 0.901 |
| CVLT, long-delay free recall | 237 | 0.551 | 0.424 | 0.195 |
| CVLT, semantic cluster ratio | 243 | −0.008 | 0.104 | 0.938 |
| CVLT, learning slope | 242 | 0.127 | 0.075 | 0.090 |
| CVLT, perseverations | 245 | 0.013 | 0.117 | 0.913 |
| CVLT, discriminability | 243 | 0.017 | 0.014 | 0.238 |
| CVLT, proactive interference | 245 | 0.102 | 0.112 | 0.366 |
| CVLT, recognition hits vs long-delay free recall | 237 | 0.392 | 0.313 | 0.210 |
| WMS, logical immediate recall | 233 | 0.180 | 0.628 | 0.775 |
| WMS, logical delayed recall | 233 | 0.133 | 0.562 | 0.813 |
| WMS, visual immediate recall | 243 | 1.016 | 0.403 | 0.012 |
| WMS, visual delayed recall | 242 | 0.696 | 0.430 | 0.107 |
| Executive function | ||||
| Trail Making Test-Part A, time to complete | 242 | −0.036 | 0.039 | 0.351 |
| Trail Making Test-Part B, time to complete | 233 | 0.003 | 0.047 | 0.947 |
| Stroop Color – Word Test, t-score | 243 | 0.374 | 0.977 | 0.702 |
| WCST, categories completed | 245 | 0.101 | 0.296 | 0.734 |
| WCST, perseverative responses | 234 | 0.085 | 0.107 | 0.427 |
| WCST, perseverative errors | 234 | 0.073 | 0.099 | 0.462 |
| WCST, failures to maintain set | 230 | 0.335 | 0.296 | 0.257 |
| Visual and spatial recognition | ||||
| Digit symbol coding | 242 | 1.713 | 1.340 | 0.202 |
| Block design | 243 | −0.044 | 1.153 | 0.969 |
| Reaction time | ||||
| Reaction time | 231 | −0.003 | 0.012 | 0.836 |
| Motor function | ||||
| Static motor steadiness, total time (dominant) | 244 | −0.031 | 0.084 | 0.713 |
| Static motor steadiness, total time (nondominant) | 242 | −0.146 | 0.131 | 0.266 |
| Pegboard completion time (dominant) | 239 | −0.029 | 0.028 | 0.298 |
| Pegboard completion time (nondominant) | 237 | −0.026 | 0.031 | 0.401 |
| Finger tapping (dominant) | 244 | −0.943 | 0.928 | 0.310 |
| Finger tapping (nondominant) | 243 | −0.587 | 0.765 | 0.444 |
| Affective state | ||||
| BDI, total score | 243 | 1.189 | 0.438 | 0.007 |
| Anxiety inventory, state anxiety t-score | 233 | −1.249 | 1.037 | 0.230 |
| Anxiety inventory, trait anxiety t-score | 243 | −0.380 | 0.935 | 0.685 |
| Olfactory function | ||||
| Smell identification test | 244 | −0.055 | 0.299 | 0.855 |
β= change in test score per unit change in log transformed lipid basis serum PCB.
Adjusted for covariates in Table 2; missing data for n < 245.
Low score = impairment.
High score = impairment.
Adjusteda mean (SE) score for CVLT), trial 1 and BDI) by total serum PCB quartile (ppb–lipid basis).
| Quartile
| |||||
|---|---|---|---|---|---|
| Domain and test | First ( | Second ( | Third ( | Fourth ( | |
| Memory and learning | |||||
| CVLT, trial 1 score | 6.66 (0.40) | 6.75 (0.40) | 6.67 (0.40) | 5.97 (0.40) | 0.057 |
| Affective state | |||||
| BDI | 5.04 (0.24) | 4.62 (0.24) | 5.48 (0.24) | 5.96 (0.25) | 0.048 |
Adjusted for covariates in Table 2.
Test for linear trend.
Final multivariate modelsa for California Verbal Learning Test (CVLT) trial 1 score and Beck Depression Inventory (BDI) with serum PCB congener concentrations (lipid basis and log transformed).
| Test | Congener | β | SE | |
|---|---|---|---|---|
| CVLT, trial 1 score | PCB-28 | 0.234 | 0.154 | 0.130 |
| PCB-74 | 0.259 | 0.168 | 0.126 | |
| PCB-99 | 0.158 | 0.151 | 0.297 | |
| PCB-105 | −0.365 | 0.155 | 0.019 | |
| PCB-118 | −0.336 | 0.154 | 0.030 | |
| PCB-138 | −0.415 | 0.200 | 0.039 | |
| PCB-153 | −0.336 | 0.229 | 0.143 | |
| PCB-170 | −0.578 | 0.255 | 0.024 | |
| PCB-180 | −0.462 | 0.218 | 0.035 | |
| PCB-183 | −0.349 | 0.201 | 0.084 | |
| PCB-187 | −0.413 | 0.249 | 0.099 | |
| PCB-194 | −0.592 | 0.294 | 0.046 | |
| BDI | PCB-28 | 0.169 | 0.250 | 0.500 |
| PCB-74 | 0.301 | 0.280 | 0.283 | |
| PCB-99 | 0.449 | 0.253 | 0.077 | |
| PCB-105 | 0.035 | 0.251 | 0.889 | |
| PCB-118 | 0.182 | 0.247 | 0.462 | |
| PCB-138 | 0.591 | 0.333 | 0.078 | |
| PCB-153 | 0.975 | 0.378 | 0.011 | |
| PCB-170 | 1.383 | 0.397 | 0.001 | |
| PCB-180 | 0.992 | 0.337 | 0.004 | |
| PCB-183 | 0.982 | 0.318 | 0.002 | |
| PCB-187 | 1.372 | 0.393 | 0.001 | |
| PCB-194 | 1.471 | 0.449 | 0.001 |
β= change in test score per unit change in log transformed lipid basis serum PCB.
Adjusted for covariates in Table 2.